Proptosis secondary to rosiglitazone treatment
International Journal of Diabetes and Metabolism. 2008; 16 (2): 89-90
em Inglês
| IMEMR
| ID: emr-86869
ABSTRACT
To report a case of new onset proptosis secondary to treatment with rosiglitazone Case report A patient developed symptomatic bilateral proptosis requiring surgical intervention, two years and a half after treatment with rosiglitazone. Asymptomatic eye protrussion is a frequent finding in patients treated with thiazolidinediones. In a few cases, the proptosis may be clinically significant and may present in patients with or without a previous history of thyroid disease
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Doenças da Glândula Tireoide
/
Tecido Adiposo
/
Exoftalmia
/
Tiazolidinedionas
/
Receptores Ativados por Proliferador de Peroxissomo
/
Insulina
Tipo de estudo:
Relato de Casos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Int. J. Diabetes Metab.
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS